03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
The UK Supreme Court on July 3 issued its judgment in Tillman v Egon Zehnder Ltd, reversing the deci...
Read More >
It is not uncommon for issues to arise when the Guaranteed Maximum Price (GMP) Proposal is submitted...
Read More >
In recent years, the autism services market has been robust. At the recent Annual Healthcare and Lif...
Read More >
In this episode of Trekking Through Compliance, we consider the episode Balance of Terror which air...
Read More >
Financial institutions M&A sector trends: payments — H1 2019 and outlook for H2 2019 - CURRENT MAR...
Read More >
The viral outbreak that exploded out of central China suddenly has captured the rapt attention of Wa...
Read More >